Medicine & Life Sciences

1. Dialysis 100%
2. Renal Dialysis 83%
3. Chronic Renal Insufficiency 67%
4. Nephrology 62%
5. Kidney Diseases 47%
6. Nephrologists 36%
7. Cinacalcet 36%
8. Hospital Rapid Response Team 33%
9. Canada 30%
10. Kidney 29%
11. Translational Medical Research 28%
12. Pandemics 22%
13. Randomized Controlled Trials 22%
14. Cost-Benefit Analysis 21%
15. Practice Guidelines 21%
16. Central Venous Catheters 20%
17. Renal Replacement Therapy 20%
18. Darbepoetin alfa 20%
19. Secondary Hyperparathyroidism 19%
20. Anemia 18%
21. Hemoglobins 16%
22. Guidelines 16%
23. Autosomal Dominant Polycystic Kidney 15%
24. Costs and Cost Analysis 15%
25. Mortality 15%
26. Catheters 15%
27. Tissue Plasminogen Activator 15%
28. Peritoneal Dialysis 14%
29. Chronic Kidney Failure 14%
30. Minerals 14%
31. Quality of Life 14%
32. Acute Kidney Injury 14%
33. Therapeutics 13%
34. Health 12%
35. Sevelamer 11%
36. Disease Progression 11%
37. Cardiovascular Diseases 11%
38. Comorbidity 10%
39. Physicians 10%
40. lanthanum carbonate 10%
41. Member 3 Solute Carrier Family 12 9%
42. Cohort Studies 9%
43. Glomerular Filtration Rate 9%
44. Confidence Intervals 9%
45. Hypertension 9%
46. Glomerulonephritis 9%
47. Placebos 9%
48. sodium thiosulfate 9%
49. Consensus 9%
50. Dalteparin 8%